Atea Pharmaceuticals, Inc.
AVIR
$4.49
$0.143.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.44M | -44.87M | -42.05M | -37.16M | -34.27M |
| Total Depreciation and Amortization | 104.00K | 104.00K | 104.00K | 104.00K | 104.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.15M | -2.58M | 3.44M | 3.35M | 5.21M |
| Change in Net Operating Assets | -4.20M | 19.12M | -1.87M | 841.00K | -1.61M |
| Cash from Operations | -46.39M | -28.22M | -40.38M | -32.87M | -30.56M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.74M | 46.59M | 41.30M | 15.29M | 85.61M |
| Cash from Investing | 29.74M | 46.59M | 41.30M | 15.29M | 85.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00M | 0.00 | 121.00K | 0.00 | 138.00K |
| Repurchase of Common Stock | -746.00K | 0.00 | -11.43M | -14.09M | -485.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 257.00K | 0.00 | -11.31M | -14.09M | -347.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.40M | 18.37M | -10.38M | -31.67M | 54.70M |